Pomalidomide-C3-NH2 hydrochloride

Background Introduction

Pomalidomide-C3-NH2 hydrochloride is a specialized E3 ligase ligand-linker conjugate. As a derivative of pomalidomide, it is engineered for use in targeted protein degradation strategies, particularly for the design and synthesis of PROTACs (Proteolysis Targeting Chimeras). This compound provides a critical building block for research focused on harnessing the ubiquitin-proteasome system for selective protein degradation.

Mechanism

Pomalidomide-C3-NH2 hydrochloride functions by binding to the E3 ubiquitin ligase cereblon (CRBN), thanks to its pomalidomide moiety. The attached C3 linker, terminated with an amine group (NH2), facilitates conjugation with various target protein ligands through amide bond formation or other linkage strategies. In a PROTAC construct, this enables the recruitment of CRBN to the target protein, resulting in its ubiquitination and subsequent proteasomal degradation, effectively removing disease-relevant or pathological proteins from cells.

Applications

Pomalidomide-C3-NH2 hydrochloride is widely used in PROTAC development workflows to create novel therapeutics and research tools. Its applications include constructing bifunctional molecules for targeted protein degradation, enabling the study of protein function, and the validation of new drug targets in oncology, neurodegeneration, immunology, and other therapeutic areas. This conjugate is also suitable for high-throughput screening, medicinal chemistry optimization, and the generation of chemical probes for biological research.

Pomalidomide-C3-NH2 hydrochloride serves as a versatile E3 Ligase Ligand-Linker Conjugate in PROTACs, enhancing targeted protein degradation through its efficient binding and degradation capabilities. The following provides a detailed description of this molecule, including its linker, ligand, and the selection of target protein ligands.

Linker: The linker in Pomalidomide-C3-NH2 hydrochloride is a C3 alkyl chain, offering moderate flexibility and stability. Its non-cleavable nature ensures sustained interaction with the target protein, making it suitable for applications requiring prolonged degradation activity.

Ligand: This molecule features pomalidomide as the ligand, a thalidomide derivative known for its high affinity and selectivity towards cereblon, an E3 ubiquitin ligase. The structural characteristics of pomalidomide facilitate effective recruitment of the ubiquitin-proteasome system.

Reactive Site: The terminal amine group in the C3 linker serves as the reactive site, enabling conjugation with target protein ligands. Recommended reaction types include amide bond formation or reductive amination, which provide stable and efficient coupling.

Recommended Target Protein Ligand: A compatible warhead for Pomalidomide-C3-NH2 hydrochloride is one that includes a functional group capable of forming covalent bonds, such as a carboxylic acid or aldehyde. These warheads are advantageous due to their ability to form stable linkages, facilitating effective degradation of target proteins in cellular environments, and are ideal for research focused on modulating protein function.